Insulin lispro
- Product NDC
- 70518-2398
- 11-digit product format
- 705182398
- Labeler code
- 70518
- Product ID
- 70518-2398_c8e8e7db-0881-6953-e053-2a95a90a3cc6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Insulin Lispro
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- REMEDYREPACK INC.
- Application
- BLA020563
- Marketing category
- BLA
- Marketing start
- 2019-10-30
- Marketing end
- 0000-00-00
- Substance
- INSULIN LISPRO
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin [Chemical/Ingredient],Insulin Analog [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2398-0 | 70518239800 | 1 VIAL in 1 CARTON (70518-2398-0) > 10 mL in 1 VIAL | 1 vial | 2019-10-30 | 0000-00-00 | No | No | Current |